In recent years, energy-based devices (EBDs), including laser systems, radiofrequency microneedling (RF), and microneedling, have been extensively utilized for skin tightening, collagen remodeling, and adipose tissue reduction. However, the interaction between these modalities and hyaluronic acid (HA) dermal fillers remains complex and incompletely understood, representing an area of ongoing investigation.
Recent studies suggest that laser treatments performed during the early post-injection period may, in certain cases, induce degradation of HA fillers, whereas other studies report minimal or no significant impact. This variability appears to be multifactorial and is primarily influenced by parameters such as the depth of filler placement, the type and energy settings of the laser device, and the temporal interval between procedures.
From a physicochemical perspective, HA fillers exhibit temperature-dependent rheological behavior. Increasing thermal exposure leads to reduced viscosity and enhanced molecular mobility. At higher temperatures, disruption of the cross-linked HA network may occur, resulting in structural degradation and accelerated resorption.
In addition to thermal effects, mechanical factors should also be considered. Procedures that induce controlled dermal injury—such as microneedling, RF-based systems, and repetitive needle penetration—may contribute to increased filler breakdown, particularly when HA is deposited in the superficial dermal plane. This effect is likely mediated by a combination of mechanical disruption, inflammatory response, and enhanced enzymatic degradation.
Fully ablative laser systems are associated with substantial thermal injury and may result in significant degradation of superficially placed HA fillers. In contrast, non-ablative fractional lasers exert variable effects depending on the delivered energy, tissue penetration depth, and the specific cross-linking technology of the HA product. Under certain conditions, these devices may affect a considerable proportion of the filler volume, and in some cases, near-complete degradation may occur.
From a clinical standpoint, appropriate treatment sequencing is critical. For patients undergoing fractional laser therapy, it is generally recommended to delay HA-based scar filler treatment for a minimum of 2 months following completion of laser sessions, allowing for tissue recovery and minimizing the risk of premature filler degradation.